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Office of the Dean
P. O. Box 1071
Knoxville, TN 37901-1071
Phone: 423/974-7262
Fax: 423/974-4773
E-mail: mshires@utk.edu

The College of Veterinary Medicine Center of Excellence has just concluded its twelfth year of
existence and its seventh year as an accomplished center. The benchmarks set at the inception of
this Center have been exceeded every year. For instance, this year the average number of peer
reviewed publications per member is over seven, indeed a remarkable achievement.
Despite recent level funding the center is growing and our faculty are achieving great success in
the very competitive area offederallnational support. One of the greatest achievements, largely
due to the center, is th~ award of an NIH Training Grant. This grant is a collaborative effort
between the College of Veterinary Medicine, Department of Pathology and the Biology Division
of the Oak Ridge National Laboratories and is to train outstanding researchers in the area of
molecular pathobiology of environmental diseases. The proposal was for $700,000 over a five
year period.
This year, we were not only reviewed by our external review committee, which review occurs
every few years, but we also had the pleasure of a review on behalf of the Tennessee Higher
Education Commission (THEC) which stated in its written review that:
"The Center has been very successful in attracting external funding. Over the past
five years, over $19 million has been awarded to the Center to support these
research projects. While the College of Veterinary Medicine is among the smallest
in the nation, it ranks fourth in external research funding."
The external reviewers' writlcn report stated:
"In conclusion, we congratulate the Dean and the faculty on the fine
accomplishments of the Center...continues to be an important asset to the
University and the State."
We will continue to refine our Center to best match areas of the most impact on Tennesseans.
Currently, the researchers of the Center cover a wide spectrum of areas- bovine mastitis, human
and animal reproduction, infectiolls diseasl:s, vaccines, animal models for important human
diseases such a polycystic kidney disease, cancer, and host defensive mechanisms important in
immune mediated diseases.
This Center of Excellence continues to be a wonderful investment with returns of almost $2.5
million per yar of external funding on a state investment of roughly $500,00 (5 :1). Would that
we could all invest so well.
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The forging of links and partnerships with other recognized institutions such as Oak Ridge
National Laboratories has enabled collaborative proposals to be submitted for funding from
external agencies that heretofore we were unable to access. These relationships should broaden
our expertise, especially in the molecular biologyltransgenic mouse areas.
One note of caution is that our state support has been level for a number of years while costs
have risen exponentially. We are very thankful for the support but with the increased price of
everything from per diem for mice to rapidly increasing spare parts for an aging electron
microscope, the Center really does need a raise. The College of Veterinary Medicine is a major
success story which shows the Tennessee taxpayers how well their money is being invested in
their, and Tennessee's, future.
We thank you for your support and we are proud to be a part of this success.

---:)
Dean
vjb

----------

1995-96 CENTER OF EXCELLENCE MEMBERS

Philip N. Bochsler, D.V.M., Ph.D.
Assistant Professor
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Professor
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Professor
Department of Animal Science

Professor
Department of Animal Science

Charmi Mendis-Handagama, D.V.M., Ph.D.
Assistant Professor
Department of Animal Science

A. Eric Schultze, D.V.M., Ph.D.
Assistant Professor
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Joyce L Merryman, D.V.M., Ph.D.
Assistant Professor
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Professor
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Mark S. Miller, Ph.D.
Assistant Professor
Department ofPatho)ogy
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Linda Munson, D.V.M., Ph.D.
Assistant Professor
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Daniel A. Ward, D.V.M., Ph.D.
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Jack W. Oliver, D.V.M., Ph.D.
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Robert M. Shull, D.V.M.

David O. Slauson, D.V.M., Ph.D.

Center of Excellence
Program Report (1995-96)
The Center of Excellence has been in existence for over eleven years. Although external
funding levels have reached a plateau over the last five to six years (approximately $2.3
million/year), the Center continues to grow in terms of its benchmarks. The Center of Excellence
can be proud, in particular, of the number of peer-reviewed articles published by participants in
1995-96 (153 total, a mean of 7.29 per member). It is a tribute to our members that they have
been able to maintain funding levels in spite of a very unfavorable funding climate.
The Center experienced considerable scrutiny this past year. First as part of the Tennessee
Higher Education Committee five-year review and second by the external scientific review team
(chaired by Dr. Peter Eyre, Dean, Virginia-Maryland Regional College of Veterinary Medicine). I
am pleased to report that the Center received excellent reviews (see Appendix) and support the
direction in which the Center is evolving.

As suggested by the external review team, we will

continue to seek an external scientific review every three years.
The essence and direction of the COE is determined by the key participants
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program. And, like any good program, the Center must be flexible to accommodate changes in
personnel and yet maintain its overall goals. We are likely to have several new participants in the
next year or two as a result of recruiting for research positions vacated because of retirement and
resignation. This infusion of new researchers into the Center can only further stimulate the vitality
of our research program. However, we realize also that subtle differences in research emphasis
may also be a consequence of filling these positions. Furthermore, changes in personnel and the
nature of external funding over the last year has provided also an opportunity for reviewing

current COE research focus areas (Inflammation and Host Defenses, Growth Factors and
Molecular Genetics, Infectious Diseases and Population Medicine, In Vitro Toxicology and
Toxicokinetics, and Carcinogenesis and Developmental Therapeutics).
Two personnel changes occurred during the year.

Dr. Ted McDonald, Professor,

Department of Animal Science retired from the University of Tennessee after 41 years of service
and Dr. Mark Miller joined the staff at Bowman Gray School of Medicine at Wake Forest
University in Winston-Salem, North Carolina.

Strategic Plan
After Dr. Potgieter took on the responsibility as Director of Research and Graduate
programs (including direct administration of the COE), it was proposed that the Dean eliminate all
standing research and COE advisory committees and replace them with a single committee to
advise the college on all research and graduate issues. It was envisaged that this committee would
have a critical role in the research and graduate training policies of the college and also be
responsible for reviewing all internal funding proposals for research or research equipment.
Although the mechanism by which this committee functions is still evolving, it has been very
active since its inception, is fulfilling its objectives, and its influence is growing.
As a consequence, the definition, policies and procedures of the COE and the description
of the research focus areas have been targets of ongoing discussion. Mechanisms to promote
greater participation and/or communication were explored .
One goal of the Center that should receive greater attention is to identify faculty with
research potential and provide appropriate venture opportunities. Therefore, this goal was placed
as one of the four priorities for funding by the Center. Also, the notion that specific faculty were

"invited to be members" of the Center is to be discontinued. It was decided to solicit proposals
from all eligible faculty (those with "significant" research appointments) and all who then receive
funding from COE would be listed as "Faculty Funded for the Fiscal Year." Of course, only
proposals that met the broad objectives of the Center would be considered.
Now all the projects supported by COE (supporting or venture) are folded into a single
competition; all researchers funded will be listed as "Faculty Funded for 199X - 199X" in future
COE reports. Also, the COE will continue to fund a modest number of summer stipends for
veterinary students to promote careers in research.
The Center of Excellence will continue to fund equipment purchases; requests will be
solicited from COE-funded researchers and recommendations for purchase by the Research and
Graduate Programs Advisory Committee will be made to the Dean and Executive Committee.

An argument was made in the five-year report that there is considerable merit in modifying
research focus areas within the Center. These arguments are valid, but in defining areas of focus,
we should also reflect our areas of strength within the Center. Some researchers have shifted
emphasis of their research on human disease slightly from exclusive use of animal models to
include also in vitro systems. This shift should be reflected in descriptions of the goals and areas
of research focus . We proposed, therefore, to use the term animal/laboratory model whenever
animal model has been used in the past.

This then will more accurately reflect what several

researchers are doing than the current terminology.
We proposed also to not only change the areas of research focus from the five that have
been operative in the immediate past to reflect the disciplines involved, but also to indicate the
connection with the mission of the Center. The new groups are:

Mission 1: Livestock Diseases 
Focus Groups:
Infectious DiseasesfPopulation Medicine
Toxicoses
Reproduction
Mission 2: AnimallLaboratory Models of Human Diseases 
Focus Groups:
Host Defense
Molecular Genetics
Carcinogenesis
This terminology reflects the relationship of our research to the mission of the Center, the
nature of the disciplines involved, and also the strengths of our researchers. Furthermore, an
established researcher is available to be assigned, based on their funded programs, to each of these
sections to serve as coordinators/leaders.

The coordinators for the six research focus groups are as follows:
Infectious DiseasesfPopulation Medicine:
Toxicoses:
Reproduction:
Host Defense:
Molecular Genetics:
Carcinogenesis:

David Brian
Terry Schultz
Linda Munson
David Slauson
Erby Wilkinson
Hildegard Schuller

The charge to the coordinators is to identify participants in each field, promote the
formation of research alliances among potential participants (particularly between applied and
basic disciplines), summarize and present research progress by faculty funded by COE
periodically, and promote dissemination of research activity of the Center.

Major Research Activity in the Center of Excellence
Goal 1
To Improve the Quality of Human Life Through Better Animal Health
Several investigators contributed to this goal. Dr. Stephen Oliver worked on bovine
mastitis to help ensure a safer food product. He has developed a highly accurate and specific
method for identification of Streptococcus bacteria in milk.
Endometriosis affects one of every seven women in the United States, resulting in pain and
infertility. In this disease, the cells that normally line the uterus grow inside the abdominal cavity,
causing organs to adhere together and become constricted and dysfunctional.

Dr. Linda Munson's goal has been the development of a model for endometriosis in
order to test factors that worsen this condition. She has developed a mouse model in which
human uterine lining cells are transplanted into the abdominal cavity. This model will be used to
develop new therapies for endometriosis.

Dr. Kevin Hahn and co-workers have conducted clinical and laboratory research trials on
client-owned pet animals with naturally-occurring cancer to identify new methods for the
diagnosis and treatment of human beings with cancer. Results from these trials have led to new
concepts in how anticancer drugs should be given to increase the potential for tumor control
(cure) and decrease the likelihood of side effects, especially in smaller-sized patients (pediatric
patients).

Dr. David Brian's laboratory investigated coronaviruses that infect many speCIes,
including cattle. By studying the molecular biology of bovine coronavirus replication, Dr. Brian
has identified potential sites in the viral genetic material for targeted anti-viral therapy and
uncovered two potential mechanisms of persistent infection.

Most excitingly, they have

discovered a potent specific antiviral molecule, a ribozyme that cleaves a vulnerable site within the
viral replication gene and blocks virus propagation. Coronaviruses infects and produces serious
disease in cattle and Brian's research provides potential opportunities for resolving the acute and
chronic coronavirus infection problems in cattle, but has applications for controlling coronavirus
infections in humans as well .

Dr. Jack Oliver's area of research emphasis continues to be the understanding and
control of the adverse effects associated with animals consuming toxic tall fescue grass. Tall
fescue is grown on 3.5 million acres in the State of Tennessee, and most of this grass is infected
with a fungus that produces toxins that harm animals (cattle, horses, sheep) that consume the
grass. Conservative estimates place the animal loss to Tennessee cattle producers alone at nearly
$100 million. In conjunction with other researchers at the University of Tennessee and the
Agricultural Experiment Station, Dr. Oliver's major activity has been concerned with a field-trial
study to determine the effectiveness of a for preventing tall fescue toxicosis. Results of this study
proved that a vaccine approach to the control of fescue toxicity was possible.
The overall research focus in Dr. Philip Bochsler's laboratory has been the investigation
of bacterial diseases of cattle.

The general purpose of this research is to gain a better

understanding of host-defense responses of cattle to disease-producing organisms.

A better

understanding of these responses is essential for understanding the pathogenesis of important
diseases of cattle, and is important for the ultimate goal of designing improved strategies to deal
with these diseases. In his work, he has studied the regulation of nitric oxide synthesis and is in
the process of characterizing the role of nitric oxide in host defense against bovine respiratory
tract disease-producing organisms.

Goal 2 
To Augment Livestock Disease Research Capabilities in the Institute of
Agriculture

Drs. P. Bochsler, S. Oliver, J. Oliver, L. Potgieter, D. Brian, J. Godkin, L. Munson,
and J. Merryman made significant contributions in livestock disease research by the Center this
past year.

Dr. Philip Bochsler's study of nitric oxide produced by certain cells and its potential
disease-producing role in the bovine lung will elucidate molecular mechanisms involved in the
bovine defense response to disease organisms, and will add useful information concerning the
development of some respiratory diseases of cattle.

Bacterial and viral infections of the

respiratory tract of cattle occur commonly in Tennessee, and are a source of significant economic
loss to the cattle industry. He has established that nitric oxide may be an important regulatory
molecule affecting the host-defense response of cattle to microbes.
Further recognition for the feasibility of an immunological approach to the control of
fescue grass toxicity occurred when Dr. Jack Oliver and co-workers were issued a patent for a
vaccine to control fescue toxicity in animals (U.S . Patent No. 5,468,486, November 11, 1995). A
comprehensive approach to monitoring toxin effect on normal body function of animals included
documenting changes in the appearance of animals, recording body weight changes, and
measuring a wide array of metabolic factors. This represented the most thorough study of tall
fescue toxin effect on cattle that had ever been done. Animals that were grazing toxic tall fescue
grass without benefit of vaccine, when compared to vaccinated cattle, grew at a slower rate, had
evidence of suppressed liver function (certain metabolic enzyme levels were less), and had bone
marrow suppression (total white blood cells and total red blood cells were less).

Dr. Leon Potgieter's work focused on the genetic variability of Respiratory Syncytial
Virus strains recovered from cattle and sheep. A portion of the viral gene that varies among
strains was targeted with a probe designed to react with the appropriate genetic material. He
determined that two subgroups of the virus affecting these animals existed. This work suggests
that a vaccine made with one strain of the virus might not provide adequate protection against
respiratory disease caused by the virus.

Dr. David Brian continued to work on bovine coronavlrus, concentrating on the
molecular biology of its replication . With funding from the USDA and the NIH, Dr. Brian has
been making an intense and systematic effort to understand how five separate genetic structural
elements in the coronavirus genome function to regulate production of viral proteins. During
acute infection, replication rates are high and during persistent infection, replication rates are low.
He studied the mechanism by which the five specific (untranslated) regions on the
messenger molecules (RNA' s) regulate the rate of viral protein synthesis (translation). They now
have obtained new information about coronaviruses that defines a specific site regulating viral
protein synthesis. This site, therefore, could be targeted for therapeutic control of coronavirus
infection.

Dr. Linda Munson's work on the development of a mouse model of endometriosis and
to test the role of a specific growth factor (platelet cell-derived) in the initiation and maintenance
of endometriosis has been successful.

She has made significant progress in developing and

characterizing cell lines of human endometrial epithelial cells, optimizing their methods for
identifying key proteins (peptides) and receptors in these cells. She confirmed that the growth
factor receptors are present in human endometriotic tissues and strengthened the relevancy of the
growth factor hypothesis. She also has made progress in transplanting endometrial cells into the
mouse and confirming the continued expression of growth factor receptors in the transplanted
cells. Transplanted cells are identified as human endometrial epithelial cells in the mice by tests
with a monoclonal antibody which does not react with mouse tissues.
Recent studies by Dr. James Godkin have focused on the factors that influence early
embryonic development leading to successful pregnancy in cattle and sheep. Vitamin A (retinol)
is essential for reproductive processes. Severe retinol deficiency may inhibit reproduction cycles,
ovarian development, and ovulation. Moderate deficiency may result in abortion, fetal resorption
or congenital abnormalities. Dr. Godkin studied the mechanisms by which retinoids (vitamin A
like chemicals) regulate cell growth and development in reproductive tissues. Recent discoveries
include the identification of retinol-binding protein (RBP), cellular-retinol binding protein (CRBP)
and cellular-retinoic acid binding protein (CRABP) in the placenta, uterus, oviduct, ovarian
follicle, egg and corpus luteum of cattle and sheep. He determined the role of ovarian sex
hormones and retinol derivatives in regulating synthesis of retinol-associated proteins in these
tissues. Research in progress is focused on developing treatments to manipulate production of
these critical proteins during ovulation and pregnancy to achieve improved reproduction
efficiency.
In addition to the studies of retinol-associated proteins, it was discovered that the uterus
and placenta of sheep and cattle produce a family of growth factors known as transforming
growth factor-beta.

Three members of this family (TBF-B-l , B2, B3) and their messenger

molecule (mRNA) are produced at different concentrations in the uterus during the estrous cycle
and pregnancy.

Sex hormone replacement studies demonstrated that each growth factor is

regulated differently by ovarian hormones.

A major research focus of Dr. Stephen Oliver has been on the bacterium Streptococcus

uberis, a frequent cause of mastitis in cows.

Strategies for controlling this mastitis-causing

organism are poorly defined and currently inadequate.

During the last year, Dr. Oliver's

laboratory has identified some factors that allow Streptococcus uberis to invade the udder and
produce mastitis.

One such factor is a capsule composed primarily of hyaluronic acid that

surrounds bacteria in at least 50% of strains, and that inhibits bacterial destruction by mammary
gland macrophages (scavenger cells). Another factor is a protein that may promote adherence of
this organism to certain cellular proteins and to mammary epithelial cells. He hypothesized that
the capsule and the protein are virulence factors involved in the development of Strep. uberis
mastitis.

The long-term goal of this research is to develop a vaccine to control this important

mastitis-producing organism.
Certain malignant tumors (squamous cell carcinomas) are common in people and are often
associated with environmental stresses such as ultraviolet radiation, cigarette smoke, and other
carcinogens. Squamous cell carcinomas probably develop because their cells are not inhibited by
a certain growth factor (TGF-p 1). This appears to be a mechanism by which normal epithelial
cells become malignant. Studies conducted by Dr. Joyce Merryman confirmed the resistance of
squamous cell carcinomas to growth-inhibition normally induced by this growth factor. But these
cells still respond by activating production of certain chemical signals within the cell. This led to
the discovery that the growth factor was incapable of activating the normal mechanisms for
repairing DNA in the tumor cells exposed to ultraviolet light. The repair mechanism is activated
by the growth factor in normal cells under similar circumstances. This fundamental research may
identify mechanisms for controlling the tumors .

Goal 3 
To Identify and Characterize Animal Diseases that are Analogous to Human
Diseases

Dr. Eric Schultze's research focused on characterizing the results of genetic changes in a
region called the fitness 1 locus in chromosome 7 of mice. Mice with mutations in the fitness 1

locus are stunted and develop growth abnormalities involving the spinal column (scoliosis).

Fitness 1 mice also have a marked deficiency in the number of red blood cells (anemia) and
evidence of liver dysfunction . Work in the laboratory centered on the investigation of iron
metabolism, a requirement for normal blood cell formation and bone growth.

Fitness 1 mice had less iron in their blood than normal mice do . The concentration of iron
in the liver of fitness 1 mice was increased, but the concentration of iron within the kidneys was
significantly less than that of normal mice. From these data, it was concluded that the anemia in

fitness 1 mice is associated with abnormal iron metabolism. The evidence of excessive storage of
iron within the liver, low serum iron concentration and biochemical evidence of liver dysfunction
suggests that the fitness 1 mouse is a good model for the disease hemochromatosis. Thefitness 1
mice constitutes a unique model that can be used to shed new light on the diagnosis and treatment
of anemia and hemochromatosis in people.

This research has broad implications for

understanding the molecular control of blood cell formation, iron metabolism, and bone growth in
mammals.
Tennessee is one of the top five air polluting states in the nation. To aid industry, state,
and local governments in making accurate judgments regarding chemical toxicity methods
predicting toxicity of chemicals such as quantitative structure-toxicity relationships and
knowledge-based expert systems, need to be developed. Phenols are a group of poisonous
bioreactive organic chemicals that have a wide variety of industrial uses. Bioreactive chemicals,
such as phenols, cause unique problems for the development of methods that predict toxicity of a
chemical.
Over the past year, Dr. Terry Schultz's laboratory has focused on developing models of
predicting chemical interactions of industrial phenols.

His laboratory has found that certain

chemical properties (the ionization constant and the quantum chemical molecular orbital term, the
lowest unoccupied molecular orbital energy) are important in predicting toxic potency of phenols.

Goal 4 
To Study Animal Models for Better Understanding of Human Disease

Several COE researchers exploited animal models in their studies over the past year of
disease processes in humans.

The investigators were Drs. C. Mendis-Handagama, Dr. T.

McDonald, J. Sackman, B. Rouse, H. Schuller, E. Schultze, D. Ward, and E. Wilkinson.
Dr. Charmi Mendis-Handagama continues her research on cellular mechanisms

associated with hormone production in the mammalian testis and ovary using the rat model.
Mouse models are extensively used by Dr. Barry Rouse and co-workers in their studies
of the immuno-biology of human herpesvirus type 1 (herpes simplexvirus). The objectives of their
work are to understand the mechanisms of the disease processes and protective immunity and the
development of effective vaccines. Significant progress was made this past year.
Dr. Hildegard Schuller has been studying the role of the autonomic nervous system in

the induction and development of lung cancer.

It has been known for years that nicotine

stimulates brain cells because it binds to a certain receptor (nicotinic acetylcholine receptor) of the
autonomic nervous system. Dr. Schuller has found also that this receptor is produced on some
types of lung cells that give rise to the most common human lung cancers and that it regulates the
growth of these cells. Nicotine is generally considered non-carcinogenic based on experiments in
laboratory animals. However, it is becoming increasingly evident that, among smokers, only those
who have a history of chronic lung disease are at high risk to develop lung cancer. Dr. Schuller
has simulated this condition in hamsters maintained in an environment with concentrations of
oxygen that are toxic to the lung. These animals developed lung cancer when given nicotine at a
concentration (0.1 mg/Kg two times/week) equivalent to that in a moderate smoker. Healthy
animals without lung injury did not develop tumors when treated with nicotine. These results
prove, for the first time, that nicotine can cause lung cancer in individuals with chronic lung
disease.
Another important finding in Dr. Schuller's laboratory was that theophylline blocks the
growth of small cell lung cancer in the laboratory while it stimulates the growth of another lung
cancer (adenocarcinoma) The mechanism by which theophylline regulates these two lung cancers
is being studied in animal models. Theophylline is the active ingredient in drugs that dilate the

bronchi and that are widely used for the treatment of asthma and bronchitis. High concentrations
of theophylline are contained also in black and green tea. If the animal experiments confirm the
laboratory data, theophylline containing drugs, as well as tea should be avoided by human patients
with lung adenocarcinoma whereas they would be beneficial for the treatment and for the
prevention of metastatic spread of small cell lung cancer.

Dr. Jill Sackman is using a dog model to investigate gene therapy via cells that line the
blood vessels (endothelial) cells. However, genetically-altered endothelial cells generally fail to
adhere to blood vessel grafts used as a vehicle to deposit the cells in an animal.

She has

determined that the mechanism for poor adhesion is an altered or missing receptor on the cells.
This information now allows the development of methods to circumvent the problem and will
enhance the development of gene therapy to treat genetic vascular diseases in humans.

Dr. Ted McDonald's laboratory continues to work on the genetic basis of a disease of
blood cells, the abnormal production of blood platelets. Certain precursor cells (megakaryocytes)
that give rise to blood platelets may contain excessively-high numbers of chromosomes and result
in over-production of blood platelets that may promote vascular disease. The mechanism by
which this condition is inherited in mice has been determined and now the role of genetic control
and thrombopoietin (a hormone affecting megakaryocytes) can be evaluated to establish potential
mechanisms of controlling the disease.

Dr. Erby Wilkinson continues to focus on the development of disease caused by specific
genetic mutations, and has exploited several mouse models for these diseases; either spontaneous
mutant mice or mice in which mutations have been induced in the laboratory. Dr. Wilkinson has
made some significant discoveries concerning the genetic kidney disease (autosomal recessive
polycystic kidney disease) . It is caused by a change in a specific gene that may be important in
cell cycle regulation. He identified a unique protein that this gene codes for. Furthermore, he
discovered cells in the liver of these mice that have characteristics of liver stem (precursor) cells
making these mice good candidates for studies of liver cancer.

Dr. Wilkinson has also identified a mouse model of auto-immune disease caused by
abnormalities in the interaction among certain lymphocytes in the developing thymus of the mouse
embryo. He is investigating the cellular and molecular basis of the disease by specific laboratory

induced mutations in these mice. Further studies this past year include the identification of mouse
models of a variety of other genetic diseases affecting various tissues and organs.

Dr. Daniel Ward continues his research in the treatment of abnormal eyelashes
(distichiasis) that cause eye irritation and the treatment of elevated intraocular pressure
(glaucoma). Using a dog model, his laboratory has conclusively demonstrated that surgical
placement of a fluid-draining device is superior to laser surgery for the treatment of severe
glaucoma.

Goal 5 
To Understand the Pathogenesis and Characterize the Causative Agents of
Common Diseases Important to the State of Tennessee

The research focus of many COE investigators is to dissect mechanisms and causes of
disease production in animals and humans. Researchers who contributed significantly to this field
over the past year included Drs. P. Bochsler, D. Brian, T. McDonald, J. Merryman,

J.

Oliver, S. Oliver, B. Rouse, H. Schuller, T. Schultz, E. Schultze, D. Ward and E.Wilkinson.
Dr. Barry Rouse and co-workers have moved closer to understanding how herpes
simplex virus infection of the eye causes an inflammatory reaction (herpetic stromal keratitis)
which often results in blindness. It seems that the virus replicates in the surface epithelial cells of
the cornea and this causes the release of chemical messengers, chemokines, which signal certain
white blood cells (neutrophils) to enter the cornea. Although these cells are mainly confined to
the deeper layers of the cornea (i .e., in the stroma), they are responsible for clearing virus. How
they accomplish this is currently under study. Dr. Rouse has evidence that either the viral
replication events or the antiviral efforts of the neutrophils damage the corneal tissues in such a
manner that triggers the host's own defense system to react with these tissues resulting in chronic
autoimmune disease. Herpetic stromal keratitis may well represent an auto-immune inflammatory
response set off by viral infection. Repair of the lesion leaves a scarred cornea that acts as screen
to light transmission and in thus partial or complete blindness.

Dr. Jack Oliver and co-workers have developed and refined a model assay system for
the effects of tall fescue grass toxin on blood vessel (endothelial) cell function . Two of the major
tall fescue compounds (alkaloids: ergine and ergovaline) were toxic to these cells. Presumably
they affect endothelial cells of animals leading to the chronic inflammatory state responsible for
tall fescue toxicity in cattle. Tall fescue toxicity may result in suppression of liver and bone
marrow function and of the immune response which could explain the superior weight gain in
cattle given a newly-developed vaccine against these toxins.
A test in ferrets, based on measuring adrenal hormones before and after stimulation of the
adrenal glands, was developed in Dr. Oliver's laboratory to detect cancerous growth of these
glands. Results of thyroid function testing in parrots indicates that stimulation of the birds with
thyrotrophic releasing hormone will allow diagnosis of certain thyroid conditions. This test will
be invaluable to detecting the most common hormonal disorder in birds because standard thyroid
tests are too variable. No other thyroid stimulation tests are currently available for birds, so the
new test procedure is an important development for improving the health of birds.

Dr. Daniel Ward has investigated factors that affect the ability of the pigmented
epithelium of the retina to protect the interior of the eye from blood-borne toxicants. Similarly, he
has shown that a certain growth factor which is produced in the eye and other tissues, also
provides protection.

Goal 6 
To Improve the Capabilities of the College of Veterinary Medicine, the College
of Agricultural Sciences and Natural Resources, and the Agricultural
Experiment Station to Deal with these Diseases

Dr. Barry Rouse's work with naked DNA vaccines, and inclusion within vaccines the
DNA encoding regulatory molecules of the immune system, has been mentioned elsewhere in this
report. However, it needs to be emphasized that this approach promises to greatly enhance the
effectiveness of vaccines and to develop vaccines to protect against a variety of diseases for which
vaccines have not been available in the past. Similarly, work in Dr. David Brian's laboratory has

resulted in the discovery of another powerful mechanism to deliver substances to an animal to
induce immunity. They found that a defective portion of a coronavirus of cattle was incapable of
producing disease but still had the capacity to divide in cells. This subviral replicon can be used,
not only to immunize animals to coronavirus, but also to carry other immunizing proteins or
therapeutic drugs into animals' tissues.
Dr. Jack Oliver, together with his co-workers, have collected additional information on
the efficacy of a novel vaccine to prevent the toxic effects of alkaloids present in tall fescue grass.
A patent has been issued for this vaccine and several commercial companies have expressed an
interest in further development of this vaccine .
Data from Dr. Robert Shull's laboratory indicate the exciting prospect that curing certain
genetic diseases by gene therapy involving a certain carrier virus is possible. In this project they
used a harmless virus, adeno-associated virus, to carry the appropriate genetic material into and to
restore the genetic defect in the tissues of dogs.

Goal 7 
To Improve Facilities to Enable the College of Veterinary Medicine to Study
More Effectively Infectious and Toxic Diseases of Animals

As mentioned in last year's report, space in the Clyde M . York Veterinary Medicine
Building for research, teaching, and clinical services is in short supply.

Collaborative COE

research is being conducted also in McCord Hall (Animal Science), Walters Life Sciences
(Microbiology), and in the Oak Ridge National Laboratory; but research space everywhere is at a
premium. It appears that funding for an animal housing facility at Cherokee Farm is now in place.
Construction should proceed this fall . Once the facility is completed, the veterinary student
surgery will be moved to Cherokee Farm, thereby, freeing approximately 3,000 square feet, some
of which will be designated for research space. Minor renovations and equipment allocations
have been made over the past year to maximize efficient use of space and to promote a multi-user
philosophy. Laboratory sharing among facuIty with similar interests and/or similar equipment
requirements has been encouraged and implemented.

Goal 8 
To Disseminate Through the Extension Service Practical Information
Required to Reduce the Incidence of Livestock Diseases

The efforts of Dr. Nancy Howell, (public information coordinator), the veterinary
extension personnel, and researchers continue to ensure that the College of Veterinary Medicine is
featured in many national, regional, and state-wide publications. Research projects and data
pertinent to Tennessee interests constitute a significant proportion of the media releases and
informational displays. Many of the research articles featured were written by COE personnel,
who have also taken advantage of invitations to speak to commodity groups at Tennessee
Agricultural Experiment Station field days and at formal extension service programs. Publications
have appeared in UT Agriculture (published for a state-wide readership by the Institute of
Agriculture), Veterinary News (for practitioners), Veterinary Medical Topics (published twice
yearly by the extension service), and two alumni publications (UT Alumnus and Torchbearer), and
in Context (UT faculty/staff newsletter). Research being conducted by the Center is disseminated
also via a computer-based program, the World-Wide Web . The University of Tennessee, College
of Veterinary Medicine has a home-page (http ://www.vet. utk. edu/vet/default. html).

Goal 9 
To Develop New Strategies for the Prevention of Disease
Dr. Barry Rouse has been investigating DNA vaccmes composed of laboratory
propagated DNA that encodes proteins of herpes simplex virus as well as proteins that act to
regulate the immune response. His laboratory was the first to show that genetic vaccines could
induce protective immunity against the virus and more recently have demonstrated that DNA
encoding HSV proteins can produce immunity in the reproductive tract following intra-nasal
immunization. This opens up the prospect of developing a new approach to the control of the
virus, an important venereal disease. Recent experiments have also revealed that the inclusion of
DNA encoding molecules that regulate the immune system may markedly influence the nature and

effectiveness of the immune response.

These findings have far-reaching implications in the

production of vaccines.
Work done in the laboratories of Drs. Jack Oliver, Hildegard Schuller, and David
Brian may also culminate in novel strategies for preventing infectious diseases, certain toxicities,
and cancer (see information under Goals 4 and 6).

Goal 10 
To Improve Facilities and Expertise in Order to Provide Improved Research
Training
Equipment
As in previous years, several multi-user pieces of equipment were bought for COE
researchers over the past year. Strategic equipment purchases last year include a Coulter
multi sizer cell counter and an image analysis system. This equipment should enhance significantly
the capacity of researchers to work with cells in the laboratory and to record and analyze nucleic
acid or protein data.

Graduate Students and Postdoctoral Researchers
In the past, the training component of the Center of Excellence has been small, but one of
high quality.

This past year, funds were used to support stipends for graduate students or

postdoctoral researchers for Drs. Brian, Godkin, S. Oliver, Rouse, Schuller, and Wilkinson.
A major achievement by the Center of Excellence has been the funding by the National
Institutes of Health of a large institutional training grant. The success of this grant application
was largely due to the efforts of Dr. David Slauson, the primary author of the proposal. The
grant will support five selected graduate students/residents in the Comparative and Experimental
Medicine Graduate Program.

The training program will be a collaborative effort of the

Department of Pathology and the biology division of the Oak Ridge National Laboratory, and will
emphasize "cellular pathobiology of environmental disease ."

The central goal of this training

effort is to provide outstanding research opportunities for young pathologists in highly focused
quality research laboratories with excellent quality control.

Dr. Karrie Brenneman is

completing her first year in the program and will be reappointed for her second year. She is
working in the laboratories of Dr. Erby Wilkinson and Dr. Rick Woychik.

Her doctoral

research will involve mice with specific experimentally-induced genetic disease.

Dr. Barbara Sheppard is the second trainee, and was appointed July 1, 1996. Dr.
Sheppard has special interests in diseases of the nervous and immune systems. She hopes to work
on the development of diseases at cellular and molecular levels.
Four graduate students and seven residents received modest COE support for their
research. Funds were allocated on a competitive basis.
Nine faculty also received modest funding for "venture" grants. The criteria for allocating
the latter included scientific merit and potential of the work to lead to future funding.

Goal 11 
To Develop Innovative Approaches to the Treatment of Human Disease

Dr. Kevin Hahn's research concerns reversing the resistance of some tumors to
anticancer drugs. Using dogs with lymphoma as an animal model, Dr. Hahn and co-workers
have identified how the tumor cell environment affects the cell's response (survival or death) to
the anticancer drug. These results have led Dr. Hahn and co-workers to pursue further research
to identify, develop, and evaluate new drugs which may change the tumor environment allowing
anti-cancer drugs to be more effective in treating drug-resistant tumors.

Dr. Robert Shull continues to make progress in research concerning restoration of a
genetic defect in children (mucopolysaccharidosis I enzyme deficiency) in a dog model of the
disease. In collaboration with Dr. Emil Kakkis, the long-term effects of genetically-engineered
products administered to reconstitute the function of the gene in dogs were studied. This year
new emphasis was placed on investigation of gene therapy administered into muscle. Five dogs
were treated with the important conclusion that such gene therapy can be severely limited by an
immune response to the desired enzyme produced in animals.
Another exciting project involved direct intramuscular injection of a novel harmless carrier
virus (vector) constructed from adeno-associated virus. The vector contained the genetic material
encoding the enzyme missing in affected dogs. Tissues of the treated animals contained high

levels of the desired enzyme, and the stage now has been set for exploring adeno-associated virus
based gene therapy.
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TABLEJ
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PROJECT
DIRECTOR

TITLE OF GRANT

FUNDING AGENCY

TOTAL
AWARDED

Philip Bochsler

The role of nitric oxide as a mediator of host
defense in cattle.

USDA 1433 Funds

$ 6,852.00
10/1/95-9/30/96

Purification and characterization of bovine
lipopolysaccharide-binding protein (renewal)

USDA

$ 184,000.00
9/1/93-8/31/96

$ 55,279.67

Molecular basis of endothelial cell sensitivity
to lipopolysaccharide

USDA

$ 95,000.00
9/15/92-8/31/95

$

David Slauson (Co-PI)

The bovine CD 14 receptor: A link in
endotoxin-mediated macrophage activation

USDA

$150,000.00
9/15/92-8/31/95

$ 22,756.76

David Brian

Bovine coronavirus vector for mucosal
immunity to phaemolytica leukotoxin

USDA

$140,000.00
9/15/95-9/14/97

$ 12,287.44

Mechanisms of coronavirus RNA
amplification.

National Institutes of Allergies and
Infectious Diseases

$118,696.00
7/1/96-6/30/2001

----------

Mechanism(s) of coronavirus RNA
replication and packaging

USDA

$200,000.00
9/1/92-6/30/96

$ 92,464.23

Retinoids in bovine follicular and oocyte
development

USDA Formula Funds

$ 5,000.00
10/1/95-9/30/96

---

Retinoid-binding protein and receptors in
bovine placental development

USDANRI

$212,000.00
9/1/93-8/31/97

$122,418.05

J ames Godkin

ESTIMATED
EXPENDITURES

3,935.46

Treatment of dogs with spontaneously
occurring osteogenic sarcoma

BYK Gulden

$ 63,890.00
1993-96

$

9,221.14

Phase II evaluation of oxorubicin in the cat

American Animal Hospital
Association

$ 10,000.00
1994-96

$

9,782.13

Development of assays for thrombopoietin

Genentech

$144,300.00
3/31/88-3/31/96

$ 48,714.49

Characterization of thrombopoietin

AMGEN

$ 74,794.00
7/1/93-6/30/96

Charmi MendisHandagama

Regulation of testosterone production in adult
rat testis

National Science Foundation

$ 18,000.00
8/15/94-1/31/97

$

Linda Munson

Contraceptive health surveillance center for
zoo and wildlife species.

Geraldine R. Dodge Foundation

$ 30,000.00
10/95-9/96

$ 12,286.11

Continuing safety assessments of
contraceptives for non-domestic felids

American Association of Zoo Parks
and Aquarium

$128,414.00
1993-97

$ 30,891.93

Characterization of serum clinical chemistry
analyte profiles of cattle grazing endophyte
free and endophyte-infected tall fescue grass.

USDA 1433 Funds

$ 10,000.00
10/1/95-9/30/96

Anti-fescue toxicosis vaccine study (Co-PI)

Merck and Company

$ 60,000.00
1/ 1/9 5-12/31/96

Endothelin response to tall fescue stimulus of
bovine endothelial cells (Co-PI)

USDA

$ 60,002.00
3/1/95-8/31/96

Identification, characterization, and
evaluation of Streptococcus uberis virulence
factors

USDA Formula Funds

$ 7,000.00
10/1/95-9/30/96

Efficacy of two novel experimental
postrnilking teat disinfectants for the
prevention of mastitis in dairy cows under
natural exposure conditions

Farnam Companies, Inc.

$ 69,600.00
1995-96

Kevin Hahn
H. Schuller, A. Legendre
(Co-PI)

Ted McDonald

Jack Oliver

Stephen Oliver

$

5,022.69

499.95

Stephen Oliver (cont'd)

Leon Potgieter

Barry Rouse

Application of DNA markers to assess the
gene associated with high somatic cell count
and mastitis in Jersey cattle

American Jersey Cattle Association

$ 6,400.00
1995-96

$ 6,400.00

DNA fingerprinting of mastitis pathogens

Dairying Research Corporation

$ 3,000.00
1995

$ 3,000.00

Experimental infection of bovine mammary
glands with Strep. Uberis

Sanofi Animal Health

$ 20,200.00
1995

$14,999.51

Influence of intramammary antibiotic therapy
at calving on mastitis and lactational
performance of heifers during early lactation

The Upjohn Company

$ 38,250.00
1995

$17,069.00

Significance of strain variation within the
ruminant respiratory syncytial virus

USDA

$123 ,310.00
9/1/93-8/31/95

$ 14,056.12

Amplification, cloning, and expression of
structural protein genes of BVD virus

The Upjohn Company

$ 85,000.00
1990-98

$ 11 ,319.88

Identification of C3 binding components that
facilitate invasion by Babesia bigemina
(Co-PI)

USDA

$130,000.00
1992-95

Detection of feline infectious peritonitis virus
and feline enteric coronavirus (Co-PI)

Morris Animal Foundation

$ 14,500.00
1994-96

$ 4,065.64

Immunity mechanisms in herpesvirus
infections

National Institute of Allergy and
Infectious Diseases - NIH

$512,245.00
1995-00

$253,362.52

Mucosal immunity in control of herpetic
infection

National Institute of Allergy and
Infectious Diseases - NIH

$538,847.00
1993-97

$164,475.66

Mechanisms of herpetic stromal keratitis

National Eye Institute - NIH

$868,717.00
1992-97

$227,648.88

Genetic vaccines and immunity to herpes
simplex

NIH

$218,607.00
1994-95

$

Liposome microencapsulation of vaccine
antigens

NIH

$785,274.00
1990-95

---------

67.24

Jill Sackman

Evaluation of the mechanisms of genetically
modified endothelial cell loss from synthetic
vascular grafts in vivo

American Heart Association

$ 80,000.00
11194-96

$ 35, 116.38

Hildegard Schuller

NNK effects on receptor pathways in normal
and neoplastic lung cells

National Cancer Institute - NIH

$599,126.00
1/94-12/96

$260,310.49

Regulation of the proliferative response of
pulmonary neuroendocrine cells to nicotinic
agonists

Verum Foundation for Behavior and
Environment

$128,484.00
1/10/96-12/31/97

$ 15,552.17

Anticarcinogenic effects of dexniguldipineMCL in hamsters

BYK-Gulden, Inc.

$380,133.00
1/ 1/9 3-12/31/96

$ 35,897.25

Characterization of induced neuroendocrine
lung cancer

National Cancer Institute - NIH

$550,791.00
2/92-1/96

$ 19,179.12

Structure-biodegradability/toxicity
relationships of substituted naphthalenes

Dupont Corp.

$ 40,000.00
6/95-6/97

Development ofbioremediation risk
management

Environmental Protection Agency

$ 34,749.00
9/94-9/96

$ 23,276.47

Photo-induced toxicity in Tetrahymena

University of Minnesota

$ 19,063 .00
1/1/94-12/31/96

$ 6,815 .16

Robert Shull

Molecular study of MPSI; gene therapy in a
canine model

University of California - Nlli

$255,055 .00
8/1/94-7/31/98

$125,940.86

David Slauson

Cellular pathobiology of environmental
disease

NIEHS - NIH

$117,496.00
7/1/95-6/30/00

$ 40,736.84

John Wilkinson

Scurfy Mouse

Lockheed Martin

$ 67,700.00
7/1/95-12/31/96

$ 34,028.67

Scurfy Mouse

Lockheed Martin

$ 41 ,391.00
10/1/95-9/30/96

$ 20,64l.74

Mammalian genetics and development

Lockheed Martin

$ 70,850.00
10/1/95-9/30/96

$ 48,925.48

Terry Schultz

Wilkinson (cont'd)

D. Slauson Co-PI

Role of the agouti gene product on
tumorogenesis

Lockheed Martin

$ 37,790.00
10/1/95-9/30/96

$ 26,185.94

Histopathologic and clinical pathology
analyses of mice from a colony containing
chromosomal translocations

Lockheed Martin

$175,600.00
7/1/95-3/21/98

$ 32,792.80

Genome analysis program

Lockheed Martin

$ 29,390.00
2/1/96-9/30/96

$

Directed expression of the agouti gene
product in transgenic mice: A potential
model for obesity

Glaxo

$672,890.00
10/1/93-9/30/96

$368,572.47

Small instrumentation grants program

NIH

$ 18,615 .00
9/1/94-8/31/95

$ 2,089.30

Molecular genetics and PKD in the
transgenic TG737 mouse

NIH

$484,523.00
9/30/93-9/29/95

$ 58,340.30

Immunobiology of the scurfy mouse

NIH

$691 ,666 ..00
9/30/92-5/31/95

$ 6,090.13

8,156.46

Barry Rouse (Co-PI)

1996-97 CENTER OF EXCELLENCE MEMBERS

Philip N. Bochsler, D.V.M., Ph.D.

Stephen P. Oliver, D.V.M., Ph.D.

Assistant Professor
Department of Pathology

Associate Professor
Department of Animal Science

David A. Brian, D.V.M., Ph.D.
Professor
Department of Microbiology

Professor
Department of Comparative Medicine

Sharon Patton, Ph.D.

James D. Godkin, Ph.D.

Leon N.D. Potgieter, B.V.Sc., Ph.D.

Professor
Department of Animal Science

Professor and Head
Department of Comparative Medicine

Kevin A. Hahn, D.V.M., Ph.D.

Barry T. Rouse, B.V.Sc., Ph.D.

Associate Professor
Department of Comparative Medicine

Professor
Department of Microbiology

Diane Hendrix, D.V.M.

Jill E. Sackman, D.V.M., Ph.D.

Assistant Professor
Department of Small Animal Clinical Sciences

Assistant Professor
Department of Small Animal Clinical Sciences

Melissa Kennedy, D.V.M., Ph.D.

Dorcas O. Schaeffer, D.V.M., M.S.

Instructor
Department of Comparative Medicine

Assistant Professor
Department of Comparative Medicine

Allen G. Mathew, Ph.D.

Hildegard M. Schuller, D.V.M., Ph.D.

Assistant Professor
Department of Animal Science

Professor
Department of Pathology

Charmi Mendis-Handagama, D.V.M., Ph.D.

Terry W. Schultz, Ph.D.

Assistant Professor
Department of Animal Science

Professor
Department of Animal Science

Joyce I. Merryman, D.V.M., Ph.D.

A. Eric Schultze, D.V.M., Ph.D.

Assistant Professor
Department of Pathology

Assistant Professor
Department of Pathology

Darryl L. Millis, M.S., D.V.M.

David O. Slauson, D.V.M., Ph.D.

Assistant Professor
Department of Small Animal Clinical Sciences

Distinguished Professor and Head
Department of Pathology

Linda Munson, D.V.M., Ph.D.

Daniel A. Ward, D.V.M., Ph.D.

Assistant Professor
Department of Pathology

Assistant Professor
Department of Small Animal Clinical Sciences

Jack W. Oliver, D.V.M., Ph.D.

J. Erby Wilkinson, D.V.M., Ph.D.

Professor
Department of Comparative Medicine

Associate Professor
Department of Pathology

Center of Excellence
1996-97
No major changes in the direction of research within the Center are anticipated for the
next year.

Most researchers have embarked on long-term research goals and some less

established members are focusing on development of a fundable research niche. Generally, the
Center's research falls within two categories, livestock diseases or animaillaboratory models of
human diseases . Researchers have concentrated on a limited number of focus areas within these
two broad categories (Livestock diseases: infectious diseases/population medicine, toxicoses and
reproduction; Animal models: host defense, molecular genetics and carcinogenesis).
The general research goals for each of the research focus groups are as follows :

Infectious Diseases/Population Medicine
Dr. Brian's laboratory will focus on the understanding of the mechanisms used by
coronaviruses for regulating genome replication and gene expression.
Dr. S. Oliver will identify virulence factors that play an important role in the development
of S. uberis mastitis and to determine whether such factors must be considered in the development
of a vaccine to control this organism.
Dr. Potgieter will work on preventing respiratory tract disease in cattle caused by
respiratory syncytial virus infections. He hopes to determine whether current vaccines are capable
of producing an adequate immunity to the disease because circumstantial evidence suggests that
vaccines are inadequate under certain circumstances.

The Center also funded two projects; one on the mechanisms by which certain bacteria
causing food-borne diseases establish themselves in the intestine in swine (Dr. A. Mathew) and
the other on the implications of infections in swine with Toxoplasma gondii (an important
parasitic disease of the nervous system and fetuses in humans) as a food-borne illness.

Toxicoses
Dr. T. Schultz will work on laboratory models capable of predicting toxicity of

bioreactive phenols. This project will provide quantitative experimental toxicity data for a number
of important industrial and environmental chemicals.
Dr. J. Oliver and co-workers will study the effect of tall fescue grass toxins on blood

vessels of cattle. Chronic exposure to the toxins results in damage to the lining of blood vessels
and mechanisms to prevent damage will be investigated. They also will work on improving the
their patented vaccine to prevent the harmful effects of the toxins.

Dr. Ward will investigate the effects of certain growth factors (bFGF, TGFB) and
chemical factors on a laboratory model of the protective outer blood-retinal barrier in the eye. It
is hoped that he can establish the same barrier that exists in the eye for protection against bloodborne toxins .

Reproduction
Dr. Godkin will conduct studies on methods that regulate the effect vitamin A-like

chemicals (retinoids) on ovarian function and early embryonic development. The long-term goal
of these studies is to identify means of improving reproductive efficiency in livestock.

Dr. Munson will study the effect of a certain growth factor (PDGF) on the development

of endometriosis, a cause of infertility.

Host Defense
Dr. Rouse will continue to work on the immunobiology of herpes simplex virus (HSV)

infection. The objectives of this work are to understand the mechanisms of herpesvirus-induced
disease processes; to get insight into the mechanisms of protective immunity against infection, and
to develop effective vaccines against HSV infection and disease.
Dr. Bochsler will continue his research studies on the role of nitric oxide as a mediator of

host defense in cattle. The goal of this study is further characterize nitric oxide generation by
certain lung cells (bovine alveolar macrophages), to determine whether synthesis of nitric oxide is
essential for killing of an important disease-producing organism of the respiratory tract of cattle,
to investigate the effect of several bovine respiratory viruses on the ability of bovine alveolar
macrophages to synthesize nitric oxide and to study the regulation of enzymes/factors responsible
for synthesis of nitric oxide.

Molecular Genetics
Dr. Mendis-Handagama will use certain tumor cells (Leydig cell line) to address the

basic questions on cholesterol transport mechanisms in the synthesis of hormones in the
mammalian testis and also investigate hormonal production in aging and developing testes using
the rat model.

Dr. Wilkinson will investigate the molecular mechanisms of several human genetic
diseases in mutant mIce.

These include polycystic kidney disease, auto-immune disease and

growth regulation.

Dr. Sackman is studying methods for to improve adhesion of genetically-altered blood
vessel cells to blood vessel grafts in her work on treatment of genetic vascular diseases.

Dr. E. Schultze will work on a mutant mouse model of a specific type of anemia in
people. He will characterize the molecular control of blood cell formation, iron metabolism and
bone growth .

Carcinogenesis
Dr. Schuller will continue to determine the molecular mechanisms by which nicotine
produces lung cancer and confirm whether drugs widely used for asthma and chronic bronchitis
promote certain kinds of lung tumors in animal models.

Dr. Hahn will identify, develop and evaluate new drugs that may augment standard anti
cancer drugs by minimizing resistance of tumor cells to the latter drugs. He also will conduct
clinical trials on client-owned pet animals with naturally-occurring cancer as models to identify
new methods for the diagnosis and treatment of cancer.

Dr. Merryman will work on new techniques to effectively evaluate the role of a certain
growth factor

{(TGF)-~}

in the development of cancer (squamous cell carcinomas).
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252 ,995

506,403

759,398

266,898

533,797

800,695

274,575

549,150

823,725

Faculty

31 ,287

62,668

93,955

29,637

59,363

89,000

30,969

62,031

93,000

Other Professional

50,555

101 ,262

151,817

35,118

70,343

105,461

37,296

74,704

112,000

Clerical! Supporting

20,937

41 ,939

62,876

20,488

41 ,039

61,527

21 ,645

43,355

65,000

Assistantships

10,027

20 ,081

30,108

19,927

39,915

59,842

20,446

40,954

61,400

112,806

225,950

338,756

105,170

210,660

315,830

110,356

221,044

331,400

25,763

51 ,603
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27,992

52,672

80,664

27,306

54,694
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277,553

416,122

133,162

263,332

Travel

1,029
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2,668

Software

2,234

4,475

6,709

0

0

450

904

1,354

0
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Other Supplies

44,653
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133,741

73,488

147,197

220,685

69,430

138,245

207,675

Equipment

60,834

121 ,852

182,686

51 ,615

103,385

155,000

56,610

113,390

170,000

Maintenance

4,772

9,560

14,332

6,901

16,415

23,316

8,741

17,509

26,250

Scholarships

454

909

1,363

400

800

1,200

800

1,600

2,400
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f37,662
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Books & Journals
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0

0

0

Renovation

0

0

0

Other (Specify)

0

0

0

0

0

0

0

0

0

0

0
<,iK
Total Non-Personnel

114,426
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775,800
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ApptndiX

The University of Tennessee
College of Veterinary Medicine
Center of Excellence in Livestock Diseases and Human Health
The Tennessee Higher Education Commission policies governing the Centers of Excellence
require that the centers be re-evaluated for continuation each five years after they are declared by
the Commission as "Accomplished Centers."
The Center was re-evaluated on February on February 9, 1996 and listed below is an excerpted
report on the Center taken from THEC Five-Year Review submitted Mary 28, 1996.
The center of Excellence in Livestock Diseases and Human Health has a unique role in addressing
the needs of animal agriculture in Tennessee and in providing a new dimension to human health
research. The College of Veterinary Medicine has been a pioneer in the use of animal models to
investigate several human diseases. It is unlikely that significant progress in understanding these
diseases could have been made if these models had not been available. Center research focuses on
the following specific five areas: inflammation and host defenses, growth factors and molecular
genetics, infectious diseases and population medicine, in vitro toxicology and toxicokinetics, and
carcinogenesis and developmental therapeutics.
To address its mission, the Center has established the following goals:
1.
2.
3.
4.
5.

To Improve the Quality of Human Life through Better Animal Health
To Augment Livestock Disease Research Capabilities in the Institute of Agriculture
To Identify and Characterize Animal Diseases that are Analogous to Human Health
To Study Animal Models for Better Understanding of Human Disease
To Understand the Pathogenesis and Characterize the Causative Agents ofCommonDiseases
Important to the State of Tennessee
6. To Improve the Capabilities of the College of Veterinary Medicine, the College of
Agricultural Sciences and Natural Resources, and the Agricultural Experiment Station to Deal
with these Diseases
7. To Improve Facilities to Enable the College of Veterinary Medicine to Study More Effectively
Infectious and Toxic Diseases of Animals
8. To Disseminate through the Extension Service Practical Information Required to Reduce the
Incidence of Livestock Diseases
9. To Develop New Strategies for the Prevention of Disease
10. To Improve Facilities and Expertise in Order to Provide Improved Research Training
11 . To Develop Innovative Approaches to the Treatment of Human Diseases

One research project has focused on white blood cells, which are an important part of the immune
system and contribute to host defense against infectious agents. This research has studied the role
of white blood cells in mediation of host defense against infectious diseases of cattle. A better
understanding of the bovine immune system is essential for understanding diseases in cattle and is
important in designing strategies for prevention and treatment of infectious diseases in cattle.
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Another research project (supported both by the National Institutes for Health and the Belgian
pharmaceutical firm, SmithKline Beecham) is searching for successful vaccines against
herpesvirus infection.
Another project has the goal of improving reproductive efficiency in livestock by reducing
stillbirths.
Certain diseases in humans also affect animals and these animals can be used to model treatment
in human subjects. One research project at the Center has focused on gene therapy for canine
genetic enzyme deficiency, a model for the identical disease which occurs in human children.
Another such project focuses in a mouse model of polycystic kidney disease, the most common
inherited disease in humans and a major cause of disease and death. Using this mouse, Center
researchers have been able to identify the first gene known to be associated with this costly and
deadly disease.
Bovine mastitis costs Tennessee producers of dairy products over $60 million annually, and tall
fescue toxicosis in cattle costs Tennessee producers another $85 million annually. Center
researchers have a model vaccine (developed with support from a large pharmaceutical firm) that
may save Tennessee farmers millions of dollars every year.
Another project has received nationwide attention: the first evidence that mothers who smoke
during pregnancy may significantly increase the risk of cancer in their children. These findings
may have a dramatic effect on prevention and treatment oflung cancer.
The Center has been very successful in attracting external funding. Over the past five years, over
$19 million has been awarded to the Center to support these research projects. While the College
of Veterinary Medicine is among the smallest in the nation, it ranks fourth in external research
funding .
The Committee recommends to the governing board and the Commission that this Accomplished
Center be continued.
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The University of Tennessee, College of Veterinary Medicine
Center of Excellent in Livestock Diseases and Human Health
Report of External Reylew

•

T~am.

March 25. 1996

OYERVIEW

Since the last visit (October 1992), the Center has continued to make good progress . It's overall
management is good and we were especially appreciative of the positive influence of Dr. Leon
Potgieter, Assistant Director, who has clearly created a better focused, goal-oriented philosophy.
This is good for the future of the Center, and should lead to even greater productivity. There has
been some restructuring since the committee's visit in 1992. The new "focus groups" for the
period 1996-2000 are different from those described in the 1990-95 report. These changes
seem appropriate and reflect the willingness of the College to encourage the evolution and
maturation of the Center.

The internal peer review process for proposals submitted for funding by the Center is functioning
especially well. Because of the potential risk that the Center may be seen as a "club" and might
exclude some faculty who may have potential to make significant research contributions,
competition for Center grants is now open to all faculty rather than a restricted group of
participants in programs of the Center. The resources of the Center should fit well with the
mission of the College and be of benefit to the whole faculty.

We feel that the External Review Board will continue to playa useful role, especially in the political
future of the Center. A four-member board (with two members rotating off periodically) seems
appropriate. Visitation every three years provides a good interval for review.

Extramural funding remains high; yet it has leveled off in recent years. This does not necessarily
represent a concern in the currently unfavorable funding climate. Efforts of the Center to better
define the focus group should enhance their competitiveness for extramural funding.

The involvement of the new COE participants (resulting from faculty retirements) will stimulate the
Center and further change its character, especially through recruitment of faculty who will
enhance the CEO's goals .

•

PROGRAM REPORTS

1.

Inflammation and host defenses

This unit continues to fare well under good leadership. Here is a good example of the
incorporation of new scientists who are changing the flavor of the COE.

Dr. Rouse

continues to be a major contributor who has garnered exceptional NIH support and plays a
vital role in graduate education. The group's partnership with the Oakridge Laboratories is
a major strength, and includes a recently funded NIH grant that will enhance graduate
training opportunities for the College.

2.

Growth factors and molecular genetics

The review team observes that this group, while continuing to be productive, seems to be
less focused than may be desirable. There are many projects of differing character,
headed in different directions. The review team is concerned about the future leadership
of this unit and recommends that ways be found to restore focus and collaborative
synergism to the group. Collaboration with Oakridge Laboratories in research involving
transgenic animals will be a valuable focus for this group.

3.

Infectious diseases and population medicjne

This is a good program which is producing excellent work. Nevertheless, the review team
strongly urges the College leadership to encourage the development of the quantitative
areas of population medicine and epidemiology. This aspect is all but absent from the
group's current interests and may prove to be a negative political issue with agricultural
groups and legislators.

We understand that the epidemiologists among the college

faculty are not participating in the COE. Perhaps there is an opportunity for the Dean to
appoint an epidemiologist to the team, as the current peer review system for membership
may fail to fill this important need.

4.

In vjtro toxicology and toxjcokjnetjcs

While this program remains an active and important part of the Center, it has suffered
major losses of people and funds . Our impression of this unit is one of several good
people going separate ways.

The group should reexamine its goals and common

interests. Great benefit would accrue from better connections with the State's diagnostic
labs, medical schools, and the Oakridge Laboratory.

5.

Carcjnogenesis and developmental therapeutics

This is a productive and innovative research enterprise that is unified behind a sovereign
director. There is no question about the thematic focus of this unit. Nevertheless, the
review team expresses concern for the growth of young scientists joining this group.
Some attention might be given to the development of a more nurturing team-oriented

environment for the good of the College: No doubt this group will continue to be highly
productive .

In conclusion, we congratulate the Dean and the faculty on the fine accomplishments of
the Center. We are honored to serve as reviewers of its programs. The COE continues to
be an important asset to the University and the State. Dr. Potgieter has provided an
important influence on the Center's success.

It will be helpful to review regularly the leadership, membership, and thematic focus of
each research program in relatio

n and goals of the COE and the College.

Peter Eyre (Virginia Tech)
Chair of Review Team
John M. Bowen, University of Georgia
Talmage T. Brown, North Carolina State University
John A. Phillips, Vanderbilt University
June 7, 1996
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